Latest Safety News

Ora Banda Mining Ltd reported a record September quarter with a 39% surge in gold production and a 37% rise in gold sales, underpinned by strong operational performance and exploration success.

Nyrada has completed its Phase I trial for Xolatryp, confirming safety and predictable pharmacokinetics, while securing AU$8.25 million to fund an upcoming Phase IIa trial targeting heart attack patients.

Challenger Gold has secured critical drilling and explosives contracts and completed refurbishment of the Casposo Toll Milling plant, marking a pivotal step toward early gold production at its Hualilán project in Argentina.

Imagion Biosystems has made significant strides toward filing an IND application for its MagSense® HER2 breast cancer imaging agent, supported by positive FDA feedback and a recent $3.5 million capital raise to fund upcoming clinical trials.

Invion Limited has partnered with Protect Animal Health to explore Photosoft™, a novel photodynamic therapy, as a treatment for cancer in companion animals, targeting a booming pet cancer market.

Pilot Energy has secured crucial environmental approval to conduct a 3D seismic survey offshore Perth Basin, propelling its exploration and farmout ambitions forward while supporting carbon storage initiatives.

Veris Limited has reversed its FY24 loss to post a $2.0 million profit before tax in FY25, driven by digital growth and strategic acquisitions. The company’s focus on higher-margin consulting and advisory services underpins a positive outlook for FY26.

PYC Therapeutics has kicked off a global Phase 1b repeat dose study of its investigational drug PYC-001 targeting Autosomal Dominant Optic Atrophy, a rare genetic eye disease with no current treatments. Initial dosing has begun, with key data expected in the second half of 2026.

Neurizon Therapeutics has been granted a key Australian patent for its lead drug candidate NUZ-001, extending protection for treatments targeting ALS, Alzheimer's, and other neurodegenerative diseases through 2041. This milestone complements earlier US patent grants and sets the stage for upcoming clinical trials.

Aurelia Metals reports a robust September 2025 quarter, with production and costs aligning to plan and key projects advancing ahead of schedule. Significant growth in copper resources and reserves underpins a confident outlook for FY26 and beyond.

Saferoads Holdings Limited reported a solid quarterly profit of $346,000, driven by strong product sales including a key order from On-site Rentals. However, the company signals caution on sustaining profitability due to market uncertainties and inventory adjustments.

Native Mineral Resources and Great Divide Mining have agreed to jointly develop and process ore from the Yellow Jack Gold Project at NMR’s Blackjack Plant, aiming to enhance regional gold production.